P3 Health Partners (PIIIW) Research & Development (2021 - 2025)
P3 Health Partners' (PIIIW) quarterly Research & Development came in at $335000.0 in Q4 2025, down 27.33% YoY from $461000.0 in Q4 2024, and up 33.47% on a QoQ basis from $251000.0 in Q3 2025.
P3 Health Partners (PIIIW) Research & Development (2021 - 2025) Analysis & Trends
P3 Health Partners (PIIIW) has 5 years of Research & Development data on file, last reported at $335000.0 in Q4 2025.
- Quarterly Research & Development fell 27.33% year-over-year to $335000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $918000.0 (down 31.03% YoY) and the FY2025 annual result came in at $918000.0, down 31.03% from the prior year.
- Research & Development improved to $335000.0 in Q4 2025, from $251000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.7 million in Q4 2022 to a low of $134000.0 in Q3 2024.
- A 5-year average of $615587.4 and a median of $461000.0 in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 294.95% — and 2024, when it slumped 79.51%.
- Tracing PIIIW's Research & Development over 5 years: stood at $491418.0 in 2021, then jumped by 246.96% to $1.7 million in 2022, then slumped by 57.71% to $721000.0 in 2023, then tumbled by 36.06% to $461000.0 in 2024, then dropped by 27.33% to $335000.0 in 2025.
- The last three Research & Development figures came in at $335000.0 (Q4 2025), $251000.0 (Q3 2025), and $151000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | - |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | - |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | - |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | P3 Health Partners | 72,590.00 | 42.30 Mn | 86.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 335,000.00 |
| Sep 30, 2025 | 251,000.00 |
| Jun 30, 2025 | 151,000.00 |
| Mar 31, 2025 | 181,000.00 |
| Dec 31, 2024 | 461,000.00 |
| Sep 30, 2024 | 134,000.00 |
| Jun 30, 2024 | 414,000.00 |
| Mar 31, 2024 | 322,000.00 |
| Dec 31, 2023 | 721,000.00 |
| Sep 30, 2023 | 654,000.00 |
| Jun 30, 2023 | 857,000.00 |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.12 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | 865,000.00 |
| Sep 30, 2021 | 491,418.00 |
| Jun 30, 2021 | 356,501.00 |
| Mar 31, 2021 | 270,241.00 |